CTRI/2023/02/050063
Completed
Phase 4
A clinical study to evaluate the efficacy and safety of the test product verses placebo in improvement of skin appearance in healthy human Volunteers.
ZeusHygia Life sciences Pvt Ltd0 sites80 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ZeusHygia Life sciences Pvt Ltd
- Enrollment
- 80
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Healthy female subjects in the age group of 35\-65 years (both age inclusive)
- •2\. Female subjects with dark spots, pimple marks and facial pigmentation
- •3\. Subjects with skin phototype IV to VI
- •4\. Females subjects with a stable hormonal status and related endocrine diseases, as
- •self\-declared by subjects.
- •5\. Subjects with minimum grade 2 of crow’s feet wrinkles as per Skin aging atlas, volume
- •IV Indian skin type, by BAZIN \& FLAMENT
- •6\. Subjects willing to give a voluntary written informed consent and comply with
- •the requirement of the study.
Exclusion Criteria
- •1\.Known hypersensitivity to any of the study products or constituents or cosmetics
- •2\. Any significant skin pathology in the test area (face)
- •3\. Currently taking any medication including food supplements, which the Investigator
- •believes may influence the interpretation of the data
- •4\. Having chronic illness or had major surgery in the last year.
- •5\. Subjects having any significant ophthalmic illness or have undergone eye surgery in the
- •past 6 months
- •6\. Subjects who has got nose piercing/ facial piercing in past 6 months
- •7\. Subjects with active/ inflamed pimple or any active lesion on the face
- •8\. Undergoing any treatment of any skin condition on their face/body
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study to evaluate the advanatges and safety of long term CurQfen consumption in dementia patientsHealth Condition 1: null- DementiaCTRI/2018/03/012410Akay Flavours and Aromatics Private Limited48
Not yet recruiting
Phase 2
A trial to check the effect of Capsule and syrup Shwasi in the management of Shwas Roga w.s.r. to Bronchial Asthma.Health Condition 1: null- Patients with Episodic Bronchial AsthmaCTRI/2018/01/011184Shree Dhanwantri Herbals Amritsar
Completed
Not Applicable
A clinical study to evaluate the efficacy and safety of docetaxel with ribavirin in patients with progressive prostate cancer who have previously recieved docetaxelJPRN-UMIN000012521Department of Urology, Keio University School of Medicine20
Not yet recruiting
Not Applicable
A clinical study to evaluate the efficacy and safety of MegaCarti® as a treatment for cartilage regeneration in patients with knee joint cartilage injury : Multicenter, microfracture control, randomization, superiority clinical trialInjury, poisoning and certain other consequences of external causesKCT0008226&C BIO64
Recruiting
Phase 2
Clinical study to evaluate the Efficacy and safety of nutraceutical formulation in neurodegenerative diseases linked to cognitive impairmentHealth Condition 1: G300- Alzheimers disease with early onsetCTRI/2022/03/040964CSIR